186 related articles for article (PubMed ID: 38034016)
1. Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome.
Pascut D; Giraudi PJ; Banfi C; Ghilardi S; Tiribelli C; Bondesan A; Caroli D; Minocci A; Grugni G; Sartorio A
Front Endocrinol (Lausanne); 2023; 14():1254778. PubMed ID: 38034016
[TBL] [Abstract][Full Text] [Related]
2. Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome.
Mele C; Grugni G; Mai S; Vietti R; Aimaretti G; Scacchi M; Marzullo P
Sci Rep; 2017 Jun; 7(1):3186. PubMed ID: 28600576
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome in adult patients with Prader-Willi syndrome.
Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
[TBL] [Abstract][Full Text] [Related]
4. Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity.
Pascut D; Tamini S; Bresolin S; Giraudi P; Basso G; Minocci A; Tiribelli C; Grugni G; Sartorio A
Endocr Connect; 2018 Dec; 7(12):1262-1274. PubMed ID: 30352401
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA Associated to Different Stages of Liver Steatosis in Prader-Willi Syndrome and Non-Syndromic Obesity.
Pratama MY; Pascut D; Tamini S; Minocci A; Tiribelli C; Grugni G; Sartorio A
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32295264
[TBL] [Abstract][Full Text] [Related]
6. Prader-Willi syndrome: endocrine manifestations and management.
Alves C; Franco RR
Arch Endocrinol Metab; 2020; 64(3):223-234. PubMed ID: 32555988
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome.
Mele C; Crinò A; Fintini D; Mai S; Convertino A; Bocchini S; Di Paolo P; Grugni G; Aimaretti G; Scacchi M; Marzullo P
J Endocrinol Invest; 2021 Jul; 44(7):1447-1456. PubMed ID: 33067796
[TBL] [Abstract][Full Text] [Related]
8. Early Diagnosis in Prader-Willi Syndrome Reduces Obesity and Associated Co-Morbidities.
Kimonis VE; Tamura R; Gold JA; Patel N; Surampalli A; Manazir J; Miller JL; Roof E; Dykens E; Butler MG; Driscoll DJ
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31698873
[TBL] [Abstract][Full Text] [Related]
9. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
10. [Extreme obesity in Prader-Willi Syndrome (PWS)].
Damiano J; Ficko C; Garrabé E; Mayaudon H; Dupuy O; Carmoi T; Bordier L; Bauduceau B
Rev Med Interne; 2003 Sep; 24(9):617-20. PubMed ID: 12951183
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
Talebizadeh Z; Butler MG
Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
[TBL] [Abstract][Full Text] [Related]
12. Autonomic nervous system dysfunction in Prader-Willi syndrome.
Butler MG; Victor AK; Reiter LT
Clin Auton Res; 2023 Jun; 33(3):281-286. PubMed ID: 36515769
[TBL] [Abstract][Full Text] [Related]
13. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome.
Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G
Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398
[No Abstract] [Full Text] [Related]
14. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome.
McAlister KL; Fisher KL; Dumont-Driscoll MC; Rubin DA
J Pediatr Endocrinol Metab; 2018 Aug; 31(8):837-845. PubMed ID: 29975666
[TBL] [Abstract][Full Text] [Related]
15. Prader-Willi syndrome and early-onset morbid obesity NIH rare disease consortium: A review of natural history study.
Butler MG; Kimonis V; Dykens E; Gold JA; Miller J; Tamura R; Driscoll DJ
Am J Med Genet A; 2018 Feb; 176(2):368-375. PubMed ID: 29271568
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated adipose tissue expansion and impaired adipogenesis in Prader-Willi syndrome children before obesity-onset.
Chao Y; Gao L; Wang X; Cai Y; Shu Y; Zou X; Qin Y; Hu C; Dai Y; Zhu M; Shen Z; Zou C
Metabolism; 2022 Nov; 136():155295. PubMed ID: 36007622
[TBL] [Abstract][Full Text] [Related]
17. Prader-Willi-like phenotypes: a systematic review of their chromosomal abnormalities.
Rocha CF; Paiva CL
Genet Mol Res; 2014 Mar; 13(1):2290-8. PubMed ID: 24737477
[TBL] [Abstract][Full Text] [Related]
18. Genomic analysis of the chromosome 15q11-q13 Prader-Willi syndrome region and characterization of transcripts for GOLGA8E and WHCD1L1 from the proximal breakpoint region.
Jiang YH; Wauki K; Liu Q; Bressler J; Pan Y; Kashork CD; Shaffer LG; Beaudet AL
BMC Genomics; 2008 Jan; 9():50. PubMed ID: 18226259
[TBL] [Abstract][Full Text] [Related]
19. Proteins and proteases of Prader-Willi syndrome: a comprehensive review and perspectives.
Basak S; Basak A
Biosci Rep; 2022 Jun; 42(6):. PubMed ID: 35621394
[TBL] [Abstract][Full Text] [Related]
20. Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review.
Pellikaan K; Nguyen NQC; Rosenberg AGW; Coupaye M; Goldstone AP; Høybye C; Markovic T; Grugni G; Crinò A; Caixàs A; Poitou C; Corripio R; Nieuwenhuize RM; van der Lely AJ; de Graaff LCG
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1720-e1730. PubMed ID: 37267430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
